{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T13:35:49Z","timestamp":1793367349973,"version":"4.5.0"},"reference-count":142,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.pbb.2024.173944","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T02:32:26Z","timestamp":1734057146000},"page":"173944","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["The synthetic cannabinoid WIN 55,212-2 attenuates cognitive and motor deficits and reduces amyloid load in 5XFAD Alzheimer mice"],"prefix":"10.1016","volume":"247","author":[{"given":"Johanna E.L.","family":"M\u00f6ller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska W.","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"G\u00fcnther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"St\u00f6ver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Bouter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.pbb.2024.173944_bb0005","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3390\/biology10060542","article-title":"Potential and limits of cannabinoids in alzheimer\u2019s disease therapy","volume":"10","author":"Abate","year":"2021","journal-title":"Biology"},{"issue":"4","key":"10.1016\/j.pbb.2024.173944_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122843","article-title":"WIN 55,212-2, agonist of cannabinoid receptors, prevents amyloid \u03b21-42 effects on astrocytes in primary culture","volume":"10","author":"Aguirre-Rueda","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.pbb.2024.173944_bb0015","doi-asserted-by":"crossref","DOI":"10.1038\/srep17338","article-title":"Alzheimer therapy with an antibody against N-terminal Abeta 4-X and pyroglutamate Abeta 3-X","volume":"5","author":"Antonios","year":"2015","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.pbb.2024.173944_bb0020","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10339-011-0430-z","article-title":"The novel object recognition memory: neurobiology, test procedure, and its modifications","volume":"13","author":"Antunes","year":"2012","journal-title":"Cogn. Process."},{"issue":"7","key":"10.1016\/j.pbb.2024.173944_bb0025","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1523\/JNEUROSCI.23-07-02511.2003","article-title":"Therapeutic action of cannabinoids in a murine model of multiple sclerosis","volume":"23","author":"Arevalo-Martin","year":"2003","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.pbb.2024.173944_bb0030","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2174\/157015907780866884","article-title":"The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration","volume":"5","author":"Ashton","year":"2007","journal-title":"Curr. Neuropharmacol."},{"issue":"2","key":"10.1016\/j.pbb.2024.173944_bb0035","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3233\/JAD-150913","article-title":"Cannabinoid receptor 2 participates in amyloid-beta processing in a mouse model of Alzheimer\u2019s disease but plays a minor role in the therapeutic properties of a Cannabis-based medicine","volume":"51","author":"Aso","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.pbb.2024.173944_bb0040","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.neuroscience.2013.09.001","article-title":"Retrieval and reconsolidation of object recognition memory are independent processes in the perirhinal cortex","volume":"253","author":"Balderas","year":"2013","journal-title":"Neuroscience"},{"issue":"35","key":"10.1016\/j.pbb.2024.173944_bb0045","doi-asserted-by":"crossref","first-page":"11136","DOI":"10.1523\/JNEUROSCI.23-35-11136.2003","article-title":"Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer\u2019s disease brains","volume":"23","author":"Benito","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2024.173944_bb0050","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s12035-007-8006-8","article-title":"The endocannabinoid system and Alzheimer\u2019s disease","volume":"36","author":"Benito","year":"2007","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.pbb.2024.173944_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2020.147135","article-title":"Endocannabinoid system alterations in Alzheimer\u2019s disease: a systematic review of human studies","volume":"1749","author":"Berry","year":"2020","journal-title":"Brain Res."},{"key":"10.1016\/j.pbb.2024.173944_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2021.173107","article-title":"Sex differences and the endocannabinoid system in pain","volume":"202","author":"Blanton","year":"2021","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2024.173944_bb0065","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fnbeh.2019.00023","article-title":"Sex differences in the behavioral and synaptic consequences of a single in vivo exposure to the synthetic cannabimimetic WIN55,212-2 at puberty and adulthood","volume":"13","author":"Borsoi","year":"2019","journal-title":"Front. Behav. Neurosci."},{"issue":"1\u20133","key":"10.1016\/j.pbb.2024.173944_bb0070","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0014-2999(03)01274-3","article-title":"The mouse light\/dark box test","volume":"463","author":"Bourin","year":"2003","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.pbb.2024.173944_bb0075","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00401-015-1489-x","article-title":"Abeta targets of the biosimilar antibodies of Bapineuzumab, Crenezumab, Solanezumab in comparison to an antibody against Ntruncated Abeta in sporadic Alzheimer disease cases and mouse models","volume":"130","author":"Bouter","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.pbb.2024.173944_bb0080","article-title":"Quantitative brain positron emission tomography in female 5XFAD Alzheimer mice: pathological features and sex-specific alterations","volume":"8","author":"Bouter","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.pbb.2024.173944_bb0085","doi-asserted-by":"crossref","DOI":"10.1007\/s00702-023-02607-8","article-title":"Chronic exposure to a synthetic cannabinoid alters cerebral brain metabolism and causes long-lasting behavioral deficits in adult mice","author":"Bouter","year":"2023","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.pbb.2024.173944_bb0090","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0079-6123(08)64021-2","article-title":"Neuropathological hallmarks of Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"117","author":"Braak","year":"1998","journal-title":"Prog. Brain Res."},{"issue":"3","key":"10.1016\/j.pbb.2024.173944_bb0095","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1101\/lm.473907","article-title":"The influence of visual ability on learning and memory performance in 13 strains of mice","volume":"14","author":"Brown","year":"2007","journal-title":"Learn. Mem."},{"issue":"5","key":"10.1016\/j.pbb.2024.173944_bb0100","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1586\/ern.11.57","article-title":"Loss of motor function in preclinical Alzheimer\u2019s disease","volume":"11","author":"Buchman","year":"2011","journal-title":"Expert. Rev. Neurother."},{"issue":"2","key":"10.1016\/j.pbb.2024.173944_bb0105","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/cne.24551","article-title":"Sex-biased hippocampal pathology in the 5XFAD mouse model of Alzheimer\u2019s disease: a multi-omic analysis","volume":"527","author":"Bundy","year":"2019","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.pbb.2024.173944_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.931384","article-title":"Effect of long-term cannabidiol on learning and anxiety in a female Alzheimer\u2019s disease mouse model","volume":"13","author":"Chesworth","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.pbb.2024.173944_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.587604","article-title":"Medium-dose chronic Cannabidiol treatment reverses object recognition memory deficits of APP (Swe)\/PS1DeltaE9 transgenic female mice","volume":"11","author":"Coles","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.pbb.2024.173944_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.962922","article-title":"Therapeutic properties of multi-cannabinoid treatment strategies for Alzheimer\u2019s disease","volume":"16","author":"Coles","year":"2022","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.pbb.2024.173944_bb0125","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/npp.2017.140","article-title":"Sex-dependent effects of Cannabis and cannabinoids: a translational perspective","volume":"43","author":"Cooper","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"10.1016\/j.pbb.2024.173944_bb0130","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.1007\/s12035-020-02054-6","article-title":"Current aspects of the endocannabinoid system and targeted THC and CBD Phytocannabinoids as potential therapeutics for Parkinson\u2019s and Alzheimer\u2019s diseases: a review","volume":"57","author":"Cooray","year":"2020","journal-title":"Mol. Neurobiol."},{"issue":"2","key":"10.1016\/j.pbb.2024.173944_bb0135","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0091-3057(80)90067-2","article-title":"Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines","volume":"13","author":"Crawley","year":"1980","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"7","key":"10.1016\/j.pbb.2024.173944_bb0140","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s40265-023-01858-9","article-title":"Anti-amyloid monoclonal antibodies are transformative treatments that redefine Alzheimer\u2019s disease therapeutics","volume":"83","author":"Cummings","year":"2023","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.pbb.2024.173944_bb0145","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1038\/s41598-022-09270-1","article-title":"Search strategy analysis of Tg4-42 Alzheimer Mice in the Morris Water Maze reveals early spatial navigation deficits","volume":"12","author":"Curdt","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pbb.2024.173944_bb2000","article-title":"Measuring motor coordination in mice","volume":"75","author":"Deacon","year":"2013","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.pbb.2024.173944_bb0150","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3389\/fpsyt.2020.00413","article-title":"Cannabinoid as beneficial replacement therapy for psychotropics to treat neuropsychiatric symptoms in severe Alzheimer\u2019s dementia: a clinical case report","volume":"11","author":"Defrancesco","year":"2020","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.pbb.2024.173944_bb0155","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1756-6606-3-34","article-title":"Sex- and brain region-specific acceleration of beta-amyloidogenesis following behavioral stress in a mouse model of Alzheimer\u2019s disease","volume":"3","author":"Devi","year":"2010","journal-title":"Mol. Brain"},{"key":"10.1016\/j.pbb.2024.173944_bb0160","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1007\/s40265-021-01569-z","article-title":"Aducanumab: first approval","volume":"81","author":"Dhillon","year":"2021","journal-title":"Drugs"},{"issue":"30","key":"10.1016\/j.pbb.2024.173944_bb0165","doi-asserted-by":"crossref","first-page":"25440","DOI":"10.1074\/jbc.M112.371757","article-title":"The synthetic cannabinoid R(+)WIN55,212-2 augments interferon-beta expression via peroxisome proliferator-activated receptor-alpha","volume":"287","author":"Downer","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.pbb.2024.173944_bb2035","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.pbb.2004.10.023","article-title":"Effects of the cannabinoid receptor agonist WIN 55,212-2 on operant behavior and locomotor activity in rats","volume":"80","author":"Drews","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.pbb.2024.173944_bb0170","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/jps.3030460322","article-title":"A note on a simple apparatus for detecting neurological deficit in rats and mice","volume":"46","author":"Dunham","year":"1957","journal-title":"J. Am. Pharm. Assoc. Am. Pharm. Assoc."},{"key":"10.1016\/j.pbb.2024.173944_bb0175","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1750-1326-8-2","article-title":"Neuron loss in the 5XFAD mouse model of Alzheimer\u2019s disease correlates with intraneuronal Abeta42 accumulation and Caspase-3 activation","volume":"8","author":"Eimer","year":"2013","journal-title":"Mol. Neurodegener."},{"issue":"4","key":"10.1016\/j.pbb.2024.173944_bb0180","first-page":"230","article-title":"The role of endocannabinoid signaling in motor control","volume":"25","author":"El Manira","year":"2010","journal-title":"Physiology (Bethesda)"},{"issue":"2","key":"10.1016\/j.pbb.2024.173944_bb0185","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1124\/jpet.113.205120","article-title":"Combined antiproliferative effects of the aminoalkylindole WIN55,212-2 and radiation in breast cancer cells","volume":"348","author":"Emery","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.pbb.2024.173944_bb0190","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0166-4328(88)90157-X","article-title":"A new one-trial test for neurobiological studies of memory in rats. 1: behavioral data","volume":"31","author":"Ennaceur","year":"1988","journal-title":"Behav. Brain Res."},{"issue":"3","key":"10.1016\/j.pbb.2024.173944_bb0195","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00109-005-0025-1","article-title":"The marijuana component cannabidiol inhibits beta-amyloid-induced tau protein hyperphosphorylation through Wnt\/beta-catenin pathway rescue in PC12 cells","volume":"84","author":"Esposito","year":"2006","journal-title":"J. Mol. Med. (Berl)"},{"issue":"1\u20132","key":"10.1016\/j.pbb.2024.173944_bb0200","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.neulet.2006.01.047","article-title":"Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in beta-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-kappaB involvement","volume":"399","author":"Esposito","year":"2006","journal-title":"Neurosci. Lett."},{"issue":"4","key":"10.1016\/j.pbb.2024.173944_bb0205","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.neuropharm.2012.05.013","article-title":"WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-gamma pathway","volume":"63","author":"Fakhfouri","year":"2012","journal-title":"Neuropharmacology"},{"issue":"7","key":"10.1016\/j.pbb.2024.173944_bb0210","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1476-5381.2008.00088.x","article-title":"The endocannabinoid system as a target for the treatment of motor dysfunction","volume":"156","author":"Fernandez-Ruiz","year":"2009","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.pbb.2024.173944_bb0215","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1089\/can.2020.0128","article-title":"The cannabinoid receptor agonist, WIN-55212-2, suppresses the activation of proinflammatory genes induced by interleukin 1 beta in human astrocytes","volume":"7","author":"Fields","year":"2022","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.pbb.2024.173944_bb0220","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pbb.2015.01.003","article-title":"Effects of WIN 55,212-2 (a synthetic cannabinoid CB1 and CB2 receptor agonist) on the anticonvulsant activity of various novel antiepileptic drugs against 6 Hz-induced psychomotor seizures in mice","volume":"130","author":"Florek-Luszczki","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.pbb.2024.173944_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41597-021-01054-y","article-title":"Systematic phenotyping and characterization of the 5xFAD mouse model of Alzheimer\u2019s disease","volume":"8","author":"Forner","year":"2021","journal-title":"Sci. Data"},{"key":"10.1016\/j.pbb.2024.173944_bb0230","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3389\/fmed.2020.00529","article-title":"In vivo imaging with (18)F-FDG- and (18)F-Florbetaben-PET\/MRI detects pathological changes in the brain of the commonly used 5XFAD mouse model of Alzheimer\u2019s disease","volume":"7","author":"Franke","year":"2020","journal-title":"Front. Med. (Lausanne)"},{"issue":"12","key":"10.1016\/j.pbb.2024.173944_bb0235","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.170228","article-title":"The role of astrocytes in amyloid production and Alzheimer\u2019s disease","volume":"7","author":"Frost","year":"2017","journal-title":"Open Biol."},{"issue":"6","key":"10.1016\/j.pbb.2024.173944_bb0240","doi-asserted-by":"crossref","first-page":"493","DOI":"10.29252\/nirp.bcn.8.6.493","article-title":"Effect of WIN55-212-2 and consequences of extinction training on conditioned fear memory in PTSD male rats","volume":"8","author":"Ghasemi","year":"2017","journal-title":"Basic Clin. Neurosci."},{"key":"10.1016\/j.pbb.2024.173944_bb0245","series-title":"A Study of the rat\u2019s Behavior in a Field. A Contribution to Method in Comparative Psychology","author":"Hall","year":"1932"},{"issue":"1","key":"10.1016\/j.pbb.2024.173944_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00504983","article-title":"Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of \u2018fear\u2019-motivated behaviour","volume":"327","author":"Handley","year":"1984","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"issue":"3","key":"10.1016\/j.pbb.2024.173944_bb0255","doi-asserted-by":"crossref","first-page":"341","DOI":"10.9758\/cpn.2020.18.3.341","article-title":"A review of behavioral tests to evaluate different types of anxiety and anti-anxiety effects","volume":"18","author":"Himanshu","year":"2020","journal-title":"Clin. Psychopharmacol. Neurosci."},{"issue":"4","key":"10.1016\/j.pbb.2024.173944_bb0260","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s40265-023-01851-2","article-title":"Lecanemab: first approval","volume":"83","author":"Hoy","year":"2023","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.pbb.2024.173944_bb0265","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jtcvs.2018.07.045","article-title":"Inhibiting a spinal cord signaling pathway protects against ischemia injury in rats","volume":"157","author":"Huo","year":"2019","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"1","key":"10.1016\/j.pbb.2024.173944_bb0270","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.neurobiolaging.2010.05.027","article-title":"Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Abeta aggregation in the 5XFAD mouse model of Alzheimer\u2019s disease","volume":"33","author":"Jawhar","year":"2012","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.pbb.2024.173944_bb0275","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1078\/0940-2993-00301","article-title":"Behavioral phenotyping of mice in pharmacological and toxicological research","volume":"55","author":"Karl","year":"2003","journal-title":"Exp. Toxicol. Pathol."},{"issue":"1","key":"10.1016\/j.pbb.2024.173944_bb0280","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.15565","article-title":"The endocannabinoid system\u2019s involvement in motor development relies on cannabinoid receptors, TRP channels, and Sonic Hedgehog signaling","volume":"11","author":"Khara","year":"2023","journal-title":"Physiol. Rep."},{"issue":"2","key":"10.1016\/j.pbb.2024.173944_bb0285","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/09540260902782810","article-title":"Cannabinoids and appetite: food craving and food pleasure","volume":"21","author":"Kirkham","year":"2009","journal-title":"Int. Rev. Psychiatry"},{"issue":"23","key":"10.1016\/j.pbb.2024.173944_bb0290","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20235905","article-title":"Cannabidiol-from plant to human body: a promising bioactive molecule with multi-target effects in cancer","volume":"20","author":"Kis","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.pbb.2024.173944_bb0295","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","article-title":"Alzheimer disease","volume":"7","author":"Knopman","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.pbb.2024.173944_bb0300","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3389\/fnins.2017.00293","article-title":"Cannabinoid receptor signaling in central regulation of feeding behavior: a mini-review","volume":"11","author":"Koch","year":"2017","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.pbb.2024.173944_bb0305","article-title":"Elevated plus maze for mice","volume":"22","author":"Komada","year":"2008","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.pbb.2024.173944_bb0310","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.bbr.2019.01.029","article-title":"Age-related changes in social behaviours in the 5xFAD mouse model of Alzheimer\u2019s disease","volume":"362","author":"Kosel","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2024.173944_bb0315","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/978-1-4939-8994-2_4","article-title":"The elevated plus maze test for measuring anxiety-like behavior in rodents","volume":"1916","author":"Kraeuter","year":"2019","journal-title":"Methods Mol. Biol."},{"issue":"10","key":"10.1016\/j.pbb.2024.173944_bb0320","doi-asserted-by":"crossref","first-page":"8332","DOI":"10.1007\/s12035-016-0313-5","article-title":"Endocannabinoid system: the direct and indirect involvement in the memory and learning processes-a short review","volume":"54","author":"Kruk-Slomka","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"9 Suppl 1","key":"10.1016\/j.pbb.2024.173944_bb0325","article-title":"Understanding metabolic homeostasis and imbalance: what is the role of the endocannabinoid system?","volume":"120","author":"Kunos","year":"2007","journal-title":"Am. J. Med."},{"issue":"2","key":"10.1016\/j.pbb.2024.173944_bb0330","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0376-8716(00)00205-2","article-title":"The pharmacological activity of inhalation exposure to marijuana smoke in mice","volume":"63","author":"Lichtman","year":"2001","journal-title":"Drug Alcohol Depend."},{"issue":"9","key":"10.1016\/j.pbb.2024.173944_bb0335","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1038\/s41386-018-0064-2","article-title":"Repeated social defeat-induced neuroinflammation, anxiety-like behavior and resistance to fear extinction were attenuated by the cannabinoid receptor agonist WIN55, 212-2","volume":"43","author":"Lisboa","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.pbb.2024.173944_bb0340","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1124\/molpharm.121.000377","article-title":"The synthetic cannabinoid WIN55,212-2 can disrupt the Golgi apparatus independent of cannabinoid receptor-1","volume":"101","author":"Lott","year":"2022","journal-title":"Mol. Pharmacol."},{"issue":"126","key":"10.1016\/j.pbb.2024.173944_bb0345","doi-asserted-by":"crossref","DOI":"10.3791\/55718","article-title":"Novel object recognition test for the investigation of learning and memory in mice","author":"Lueptow","year":"2017","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.pbb.2024.173944_bb0350","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neuroscience.2020.07.045","article-title":"Effect of the endocannabinoid system in memory updating and forgetting","volume":"444","author":"Lunardi","year":"2020","journal-title":"Neuroscience"},{"issue":"8","key":"10.1016\/j.pbb.2024.173944_bb0355","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1016\/j.pnpbp.2011.07.001","article-title":"Effects of WIN 55,212-2 mesylate (a synthetic cannabinoid) on the protective action of clonazepam, ethosuximide, phenobarbital and valproate against pentylenetetrazole-induced clonic seizures in mice","volume":"35","author":"Luszczki","year":"2011","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.pbb.2024.173944_bb0360","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9091270","article-title":"WIN55,212-2 attenuates cognitive impairments in AlCl(3) + d-galactose-induced Alzheimer\u2019s disease rats by enhancing neurogenesis and reversing oxidative stress","volume":"9","author":"Mahdi","year":"2021","journal-title":"Biomedicines"},{"issue":"8 Suppl","key":"10.1016\/j.pbb.2024.173944_bb0365","first-page":"S167","article-title":"Current and evolving treatment strategies for the Alzheimer disease continuum","volume":"26","author":"Marasco","year":"2020","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.pbb.2024.173944_bb0370","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/978-3-540-88955-7_8","article-title":"Roles of the endocannabinoid system in learning and memory","volume":"1","author":"Marsicano","year":"2009","journal-title":"Curr. Top. Behav. Neurosci."},{"issue":"2","key":"10.1016\/j.pbb.2024.173944_bb2010","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0306-4522(98)00052-9","article-title":"Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-naive mice","volume":"85","author":"Martellotta","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2024.173944_bb0375","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00213-001-0946-5","article-title":"Involvement of CB1 cannabinoid receptors in emotional behaviour","volume":"159","author":"Martin","year":"2002","journal-title":"Psychopharmacology"},{"issue":"6","key":"10.1016\/j.pbb.2024.173944_bb0380","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/npp.2010.6","article-title":"Differential regulation of behavioral tolerance to WIN55,212-2 by GASP1","volume":"35","author":"Martini","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.pbb.2024.173944_bb0385","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1124\/mol.111.071290","article-title":"Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer\u2019s disease","volume":"79","author":"Martin-Moreno","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.pbb.2024.173944_bb0390","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1742-2094-9-8","article-title":"Prolonged oral cannabinoid administration prevents neuroinflammation, lowers beta-amyloid levels and improves cognitive performance in Tg APP 2576 mice","volume":"9","author":"Martin-Moreno","year":"2012","journal-title":"J. Neuroinflammation"},{"issue":"3","key":"10.1016\/j.pbb.2024.173944_bb0395","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/0091-3057(95)02066-7","article-title":"Aversive effects of the synthetic cannabinoid CP 55,940 in rats","volume":"53","author":"McGregor","year":"1996","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2024.173944_bb0400","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00213-008-1209-5","article-title":"An endocannabinoid signaling system modulates anxiety-like behavior in male Syrian hamsters","volume":"200","author":"Moise","year":"2008","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.pbb.2024.173944_bb0405","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0165-0270(84)90007-4","article-title":"Developments of a water-maze procedure for studying spatial learning in the rat","volume":"11","author":"Morris","year":"1984","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.pbb.2024.173944_bb2040","doi-asserted-by":"crossref","unstructured":"F.M. Mouro, V.L. Batalha, D.G. Ferreira, J.E. Coelho, Y. Baqi, C.E. Muller, L.V. Lopes, J.A. Ribeiro, A.M. Sebastiao, Chronic and acute adenosine A(2A) receptor blockade prevents long-term episodic memory disruption caused by acute cannabinoid CB(1) receptor activation, Neuropharmacology 117.","DOI":"10.1016\/j.neuropharm.2017.02.021"},{"issue":"1","key":"10.1016\/j.pbb.2024.173944_bb0410","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/jnc.14549","article-title":"Chronic, intermittent treatment with a cannabinoid receptor agonist impairs recognition memory and brain network functional connectivity","volume":"147","author":"Mouro","year":"2018","journal-title":"J. Neurochem."},{"issue":"7","key":"10.1016\/j.pbb.2024.173944_bb0415","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.4155\/fmc.09.93","article-title":"Cannabinoids as novel anti-inflammatory drugs","volume":"1","author":"Nagarkatti","year":"2009","journal-title":"Future Med. Chem."},{"issue":"40","key":"10.1016\/j.pbb.2024.173944_bb0420","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","article-title":"Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation","volume":"26","author":"Oakley","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2024.173944_bb0425","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.713726","article-title":"Comprehensive evaluation of the 5XFAD mouse model for preclinical testing applications: a MODEL-AD study","volume":"13","author":"Oblak","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.pbb.2024.173944_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2023.101239","article-title":"Endocannabinoid signaling in adult hippocampal neurogenesis: a mechanistic and integrated perspective","volume":"91","author":"Oddi","year":"2023","journal-title":"Prog. Lipid Res."},{"issue":"4","key":"10.1016\/j.pbb.2024.173944_bb0435","article-title":"Visuo-spatial learning and memory impairments in the 5xFAD mouse model of Alzheimer\u2019s disease: effects of age, sex, albinism, and motor impairments","volume":"21","author":"O\u2019Leary","year":"2022","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.pbb.2024.173944_bb0440","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.bbr.2017.09.009","article-title":"Motor function deficits in the 12 month-old female 5xFAD mouse model of Alzheimer\u2019s disease","volume":"337","author":"O\u2019Leary","year":"2018","journal-title":"Behav. Brain Res."},{"issue":"3","key":"10.1016\/j.pbb.2024.173944_bb0445","article-title":"Age-related deterioration of motor function in male and female 5xFAD mice from 3 to 16 months of age","volume":"19","author":"O\u2019Leary","year":"2020","journal-title":"Genes Brain Behav."},{"issue":"12","key":"10.1016\/j.pbb.2024.173944_bb0450","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1111\/bph.13497","article-title":"An update on PPAR activation by cannabinoids","volume":"173","author":"O\u2019Sullivan","year":"2016","journal-title":"Br. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.pbb.2024.173944_bb0455","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.jagp.2021.01.015","article-title":"Cannabinoids for agitation in Alzheimer\u2019s disease","volume":"29","author":"Outen","year":"2021","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.pbb.2024.173944_bb0460","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.659012","article-title":"Genetic modulation of initial sensitivity to Delta9-tetrahydrocannabinol (THC) among the BXD family of mice","volume":"12","author":"Parks","year":"2021","journal-title":"Front. Genet."},{"issue":"6","key":"10.1016\/j.pbb.2024.173944_bb0465","first-page":"1029","article-title":"WIN induces apoptotic cell death in human colon cancer cells through a block of autophagic flux dependent on PPARgamma down-regulation","volume":"19","author":"Pellerito","year":"2014","journal-title":"Apoptosis"},{"issue":"3","key":"10.1016\/j.pbb.2024.173944_bb0470","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0165-0270(85)90031-7","article-title":"Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat","volume":"14","author":"Pellow","year":"1985","journal-title":"J. Neurosci. Methods"},{"issue":"5-6","key":"10.1016\/j.pbb.2024.173944_bb2015","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.lfs.2009.05.015","article-title":"Behavioural and dopaminergic alterations induced by a low dose of WIN 55,212-2 in a conditioned place preference procedure","volume":"85","author":"Polissidis","year":"2009","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.pbb.2024.173944_bb0475","doi-asserted-by":"crossref","DOI":"10.3390\/cells12050780","article-title":"Sex differences between neuronal loss and the early onset of amyloid deposits and behavioral consequences in 5xFAD transgenic mouse as a model for Alzheimer\u2019s disease","volume":"12","author":"Poon","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.pbb.2024.173944_bb0480","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF02244975","article-title":"Evidence for separate neuronal mechanisms for the discriminative stimulus and catalepsy induced by \u0394 9-THC in the rat","volume":"107","author":"Prescott","year":"1992","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.pbb.2024.173944_bb0485","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/sj.bjp.0705778","article-title":"Cannabinoid receptor-independent actions of the aminoalkylindole WIN 55,212-2 on trigeminal sensory neurons","volume":"142","author":"Price","year":"2004","journal-title":"Br. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.pbb.2024.173944_bb0490","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1111\/j.1460-9568.2009.06764.x","article-title":"WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson\u2019s disease","volume":"29","author":"Price","year":"2009","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.pbb.2024.173944_bb0495","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13195-016-0188-8","article-title":"Recent global trends in the prevalence and incidence of dementia, and survival with dementia","volume":"8","author":"Prince","year":"2016","journal-title":"Alzheimers Res. Ther."},{"issue":"1-2","key":"10.1016\/j.pbb.2024.173944_bb2020","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejphar.2005.05.014","article-title":"WIN 55,212-2-induced reduction of cocaine hyperlocomotion: possible inhibition of 5-HT(3) receptor function","volume":"517","author":"Przegalinski","year":"2005","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.pbb.2024.173944_bb0500","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/imm.13378","article-title":"Endocannabinoids in immune regulation and immunopathologies","volume":"164","author":"Rahaman","year":"2021","journal-title":"Immunology"},{"issue":"8","key":"10.1016\/j.pbb.2024.173944_bb0505","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1523\/JNEUROSCI.4540-04.2005","article-title":"Prevention of Alzheimer\u2019s disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation","volume":"25","author":"Ramirez","year":"2005","journal-title":"J. Neurosci."},{"issue":"12","key":"10.1016\/j.pbb.2024.173944_bb0510","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1038\/npp.2012.123","article-title":"Biphasic effects of cannabinoids in anxiety responses: CB1 and GABAB receptors in the balance of GABAergic and glutamatergic neurotransmission","volume":"37","author":"Rey","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.pbb.2024.173944_bb0515","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/alcalc\/agh110","article-title":"The endocannabinoid system: physiology and pharmacology","volume":"40","author":"Rodriguez de Fonseca","year":"2005","journal-title":"Alcohol Alcohol."},{"issue":"2","key":"10.1016\/j.pbb.2024.173944_bb0520","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11020599","article-title":"Search strategy analysis of 5xFAD Alzheimer mice in the Morris water maze reveals sex- and age-specific spatial navigation deficits","volume":"11","author":"Sanchez","year":"2023","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.pbb.2024.173944_bb0525","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0014-2999(00)00044-3","article-title":"Activational role of cannabinoids on movement","volume":"391","author":"Sa\u00f1udo-Pe\u00f1a","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2024.173944_bb0530","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3389\/fnbeh.2019.00094","article-title":"Prolonged cannabidiol treatment lacks on detrimental effects on memory, motor performance and anxiety in C57BL\/6J mice","volume":"13","author":"Schleicher","year":"2019","journal-title":"Front. Behav. Neurosci."},{"issue":"1","key":"10.1016\/j.pbb.2024.173944_bb0535","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006189","article-title":"Neuropathological alterations in Alzheimer disease","volume":"1","author":"Serrano-Pozo","year":"2011","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.pbb.2024.173944_bb0540","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.949361","article-title":"Targeting the cannabinoid system to counteract the deleterious effects of stress in Alzheimer\u2019s disease","volume":"14","author":"Shade","year":"2022","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.pbb.2024.173944_bb0545","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12915-023-01679-y","article-title":"Four-parameter analysis in modified Rotarod test for detecting minor motor deficits in mice","volume":"21","author":"Shan","year":"2023","journal-title":"BMC Biol."},{"issue":"2","key":"10.1016\/j.pbb.2024.173944_bb0550","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jneumeth.2010.03.026","article-title":"A rotarod test for evaluation of motor skill learning","volume":"189","author":"Shiotsuki","year":"2010","journal-title":"J. Neurosci. Methods"},{"issue":"2","key":"10.1016\/j.pbb.2024.173944_bb0555","doi-asserted-by":"crossref","first-page":"755","DOI":"10.3233\/JAD-210523","article-title":"Sex differences in behavior and molecular pathology in the 5XFAD model","volume":"85","author":"Sil","year":"2022","journal-title":"J. Alzheimers Dis."},{"issue":"1607","key":"10.1016\/j.pbb.2024.173944_bb0560","first-page":"3193","article-title":"Endocannabinoids in nervous system health and disease: the big picture in a nutshell","volume":"367","author":"Skaper","year":"2012","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"issue":"11","key":"10.1016\/j.pbb.2024.173944_bb0565","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1111\/acer.14197","article-title":"Assessment of acute motor effects and tolerance following self-administration of alcohol and edible \u2206(9)-tetrahydrocannabinol in adolescent male mice","volume":"43","author":"Smoker","year":"2019","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"1","key":"10.1016\/j.pbb.2024.173944_bb0570","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1089\/can.2017.0002","article-title":"Cannabinoids in Parkinson\u2019s disease","volume":"2","author":"Stampanoni Bassi","year":"2017","journal-title":"Cannabis Cannabinoid Res."},{"issue":"2","key":"10.1016\/j.pbb.2024.173944_bb0575","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0091-3057(97)00422-X","article-title":"Biphasic effects of anandamide","volume":"59","author":"Sulcova","year":"1998","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2024.173944_bb0580","article-title":"Cannabinoids as key regulators of inflammasome signaling: a current perspective","volume":"11","author":"Suryavanshi","year":"2020","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.pbb.2024.173944_bb0585","doi-asserted-by":"crossref","first-page":"176","DOI":"10.2174\/1570159X16666180702144644","article-title":"Modulation of the cannabinoid system: a new perspective for the treatment of the Alzheimer\u2019s disease","volume":"17","author":"Talarico","year":"2019","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.pbb.2024.173944_bb0590","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fneur.2020.00087","article-title":"Endocannabinoid modulation of microglial phenotypes in neuropathology","volume":"11","author":"Tanaka","year":"2020","journal-title":"Front. Neurol."},{"issue":"36","key":"10.1016\/j.pbb.2024.173944_bb0595","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.11353","article-title":"Spatial learning and memory impairments are associated with increased neuronal activity in 5XFAD mouse as measured by manganese-enhanced magnetic resonance imaging","volume":"7","author":"Tang","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.pbb.2024.173944_bb0600","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2012.04.021","article-title":"The role of astrocytes in amyloid beta-protein toxicity and clearance","volume":"236","author":"Thal","year":"2012","journal-title":"Exp. Neurol."},{"issue":"6","key":"10.1016\/j.pbb.2024.173944_bb2025","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1111\/adb.12446","article-title":"Chronic exposure to cannabinoids during adolescence causes long-lasting behavioral deficits in adult mice","volume":"22","author":"Tomas-Roig","year":"2017","journal-title":"Addict. Biol."},{"issue":"1","key":"10.1016\/j.pbb.2024.173944_bb2030","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41598-019-57290-1","article-title":"Dose-dependent effect of cannabinoid WIN-55,212-2 on myelin repair following a demyelinating insult","volume":"10","author":"Tomas-Roig","year":"2020","journal-title":"Sci. Rep."},{"issue":"4\u20135","key":"10.1016\/j.pbb.2024.173944_bb0605","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0010-9452(08)70877-3","article-title":"Contributions of thalamic nuclei to declarative memory functioning","volume":"39","author":"Van Der Werf","year":"2003","journal-title":"Cortex"},{"key":"10.1016\/j.pbb.2024.173944_bb0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173554","article-title":"Alzheimer\u2019s disease: recent treatment strategies","volume":"887","author":"Vaz","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2024.173944_bb0615","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.bbr.2014.01.037","article-title":"Cannabinoid receptor agonist disrupts behavioral and neuroendocrine responses during lactation","volume":"263","author":"Vilela","year":"2014","journal-title":"Behav. Brain Res."},{"issue":"9","key":"10.1016\/j.pbb.2024.173944_bb0620","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/(SICI)1099-1166(199709)12:9<913::AID-GPS663>3.0.CO;2-D","article-title":"Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer\u2019s disease","volume":"12","author":"Volicer","year":"1997","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.pbb.2024.173944_bb0625","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fnbeh.2019.00107","article-title":"Analysis of motor function in the Tg4-42 mouse model of Alzheimer\u2019s disease","volume":"13","author":"Wagner","year":"2019","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.pbb.2024.173944_bb0630","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s00213-006-0343-1","article-title":"Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia","volume":"185","author":"Walther","year":"2006","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.pbb.2024.173944_bb0635","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/JCP.0b013e31820e861c","article-title":"Randomized, controlled crossover trial of dronabinol, 2.5 mg, for agitation in 2 patients with dementia","volume":"31","author":"Walther","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.pbb.2024.173944_bb0640","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.psychres.2018.06.012","article-title":"The potential protective effects of cannabinoid receptor agonist WIN55,212-2 on cognitive dysfunction is associated with the suppression of autophagy and inflammation in an experimental model of vascular dementia","volume":"267","author":"Wang","year":"2018","journal-title":"Psychiatry Res."},{"issue":"8","key":"10.1016\/j.pbb.2024.173944_bb0645","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/j.neuropsychologia.2009.12.022","article-title":"Findings from animals concerning when interactions between perirhinal cortex, hippocampus and medial prefrontal cortex are necessary for recognition memory","volume":"48","author":"Warburton","year":"2010","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.pbb.2024.173944_bb0650","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fgene.2014.00088","article-title":"Using mice to model Alzheimer\u2019s dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models","volume":"5","author":"Webster","year":"2014","journal-title":"Front. Genet."},{"key":"10.1016\/j.pbb.2024.173944_bb0655","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neulet.2014.05.057","article-title":"Sex differences in Delta(9)-tetrahydrocannabinol metabolism and in vivo pharmacology following acute and repeated dosing in adolescent rats","volume":"576","author":"Wiley","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pbb.2024.173944_bb0660","doi-asserted-by":"crossref","DOI":"10.1177\/1179573520907397","article-title":"Current and future treatments in Alzheimer disease: an update","volume":"12","author":"Yiannopoulou","year":"2020","journal-title":"J. Cent. Nerv. Syst. Dis."},{"issue":"15","key":"10.1016\/j.pbb.2024.173944_bb0665","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22158208","article-title":"Novel therapeutic approaches for Alzheimer\u2019s disease: an updated review","volume":"22","author":"Yu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pbb.2024.173944_bb0670","series-title":"Handbook of Natural Fibres","first-page":"419","article-title":"Medical potential of Cannabis: an overview","author":"Zielonka","year":"2020"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305724002387?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305724002387?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T09:20:46Z","timestamp":1769505646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305724002387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":142,"alternative-id":["S0091305724002387"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2024.173944","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The synthetic cannabinoid WIN 55,212-2 attenuates cognitive and motor deficits and reduces amyloid load in 5XFAD Alzheimer mice","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2024.173944","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"173944"}}